Stay updated on Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Sign up to get notified when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.

Latest updates to the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page
- Check4 days agoChange DetectedThe NCT01170065 record is available with details of a completed Phase 2 rollover study of BIBF 1120 (nintedanib) for idiopathic pulmonary fibrosis, including participant criteria, study locations, and reported outcomes.SummaryDifference70%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn NIH-wide notice about updated terminology appears above the unchanged 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe footer’s displayed site revision changes from v3.7.0 to v3.7.1; the page continues to show a 403 error.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study record content and navigation. Access to the study details is no longer available on this page.SummaryDifference17%

- Check60 days agoChange DetectedThe page shows a new revision identifier, updating from v3.6.6 to v3.7.0. This reflects a system or UI version upgrade rather than a change to study content or data.SummaryDifference0.0%

Stay in the know with updates to Roll Over Study 1199.30 BIBF 1120 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roll Over Study 1199.30 BIBF 1120 Clinical Trial page.